)
Sotera Health Company (SHC) investor relations material
Sotera Health Company Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2025 net revenues rose 9.1% to $311 million, with net income up 184.7% to $48 million ($0.17 per diluted share), and double-digit adjusted EBITDA growth and margin expansion.
Sterigenics and Nordion delivered double-digit revenue and segment income growth year-over-year; Nelson Labs expanded segment income margin by 229 bps despite lower revenue.
Completed a $75 million term loan repayment, reducing annual interest expense by $13 million, and executed a secondary offering of 20 million shares.
Nordion secured a 25-year renewal of its Class 1B operating license, the longest ever granted by the Canadian Nuclear Safety Commission.
Management reaffirmed 2025 revenue outlook and raised adjusted EBITDA and EPS guidance due to strong year-to-date results and visibility.
Financial highlights
Q3 2025 revenues reached $311 million, up 9.1% year-over-year (8% constant currency); net income was $48 million ($0.17 per diluted share), up from $17 million ($0.06) in Q3 2024.
Adjusted EBITDA grew 12.2% to $164 million (11.2% constant currency), with margins at 52.7%, up 147 basis points.
Adjusted EPS was $0.26, up $0.09 year-over-year, with $0.04 from EBITDA growth and the rest from lower interest and tax rate.
Gross profit for Q3 2025 was $177.6 million, up from $158.0 million in Q3 2024.
Interest expense improved to $39 million, down $2.4 million year-over-year, with net leverage ratio improved to 3.3x as of Q3 2025.
Outlook and guidance
Full-year 2025 constant currency revenue growth outlook maintained at 4.5%–6%, expecting to land near the midpoint.
Raised constant currency adjusted EBITDA growth outlook to 6.75%–7.75% (from 6%–7.5%).
Adjusted EPS guidance increased to $0.81–$0.86, reflecting improved EBITDA, lower interest, and tax rate.
Capital expenditures expected at $125 million–$135 million, below prior outlook due to project timing and cost savings.
Net leverage ratio improved to 3.3x, with further improvement expected by year-end 2025.
Next Sotera Health Company earnings date
Next Sotera Health Company earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)